The largest database of trusted experimental protocols

Luciferase mrna

Manufactured by Promega
Sourced in United Kingdom, United States

Luciferase mRNA is a genetic construct that encodes the luciferase enzyme. Luciferase is a bioluminescent protein that catalyzes a reaction that produces light. This mRNA can be used to express the luciferase protein in cells or organisms.

Automatically generated - may contain errors

12 protocols using luciferase mrna

1

Testis RNA Isolation and cDNA Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was isolated from frozen testes using the RNeasy Mini extraction kit with RNase-free DNase on-the-column digestion kit (Qiagen, Crawley, UK) according to the manufacturer’s instructions. Due to changes in testis cell composition and size during normal development or due to the impact of gene deletion/treatment, 5 ng of luciferase mRNA (Promega, UK) was added per testis prior to RNA extraction as an external control to allow for direct comparison between samples59 (link). RNA was quantified using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) andcDNA was prepared using the SuperScript VILO cDNA synthesis kit (Life Technologies) according to manufacturer’s instructions.
+ Open protocol
+ Expand
2

Luciferase mRNA Translation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Translation occured in an incubation mixture (25 μl) containing 17.5 μl of nuclease-treated rabbit reticulocyte lysate (RRL) (Promega), amino acids (20 μM), buffer (10 mM Hepes, pH 7.5, 20 mM KCl), 200 ng of Luciferase mRNA (Promega) and YB-1 or YB-1C proteins at indicated concentrations. Luciferase mRNA was capped using Vaccinia Capping System according to the manufacturer’s recommendations (NEB). Translation was performed at 30°C for 10 min and 5 μl of the translation reaction was loaded onto 10% acrylamide gel. Proteins produced during the reaction and control proteins were visualized by western-blotting using specific antibody (anti-Luciferase (Sigma catalog number), anti-YB-1 (59-Q, Santa Cruz, epitope: aa 51–140), anti_RPL10A (Abcam ab187998). The DNA construct (57 (link)) consisting in two ssDNA loop (5000 and 1500 nt) separated by a dsDNA (300 bp) stalk is a gift from Dr Enrique Viguera Mínguez.
+ Open protocol
+ Expand
3

Quantitative RNA Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA extraction, reverse transcription, primer design and real-time PCR were carried out as previously described [11 (link),12 (link)][15 (link),16 (link)]. RNA was extracted using TRIzol (Life Technologies, Paisley, UK). Luciferase mRNA (5ng per testis, Promega UK, Southampton, UK) was added as an external standard to each sample at the start of the RNA extraction procedure. This controls for the efficiency of RNA extraction, RNA degradation, and the reverse transcription step and allows specific transcript levels to be expressed per testis. Isolated RNA was reverse transcribed using random hexamers and Moloney murine leukemia virus reverse transcriptase (Superscript III; Life Technologies). For real-time PCR, SYBR mastermix (Brilliant II, Agilent, Amsterdam, The Netherlands) was mixed with primer (100 nM) and template in a total volume of 10μl and amplified with an Agilent MX3000 cycler. All primers were designed by PrimerExpress 2.0 (Applied Biosystems, Warrington, UK). Transcript levels were normalised relative to the luciferase external standard, generating a value of transcript expression per testis. The primers used are described in S1 Table.
+ Open protocol
+ Expand
4

Quantifying Gene Expression in Mouse Testes

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was isolated from frozen testes from 8, 80-d-old LCARKO and 8 control mice, or 6 Adipo-ARKO or 6 control mice, using the RNeasy Mini extraction kit with RNase-free DNase on the column digestion kit (QIAGEN) according to the manufacturer’s instructions. For quantitative RT-PCR, 5 ng Luciferase mRNA (Promega Corporation, Madison, WI, USA) was added to each testis sample before RNA extraction as an external standard (41 (link)). RNA was quantified using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). Random hexamer-primed cDNA was prepared using the SuperScript VILO cDNA Synthesis Kit (Life Technologies, Grand Island, NY, USA) according to the manufacturer’s instructions. Quantitative PCR was performed on 80-d-old LCARKO and control testes for the genes listed in Table 2, using an ABI Prism 7900 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) and the Roche Universal Probe library (Welwyn, United Kingdom), as described previously (30 (link)). The expression of each gene was related to an external positive control luciferase, as published previously (42 (link)), and all genes were expressed per testis.
+ Open protocol
+ Expand
5

Exogenous mRNA Recovery Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luciferase mRNA (Promega) was used as the exogenous internal reference (ref mRNA) to estimate the percentage of RNA loss during extraction. After the centrifugation of the lysed cells, 1 μL of a range of 1 × 1011 to 1 × 107ref mRNA transcripts/μL were added to the aqueous phase. After RNA extraction, the amount of ref mRNA recovered from samples was measured by qPCR and the standard curve generated from serial dilutions of ref mRNA. The recovery fraction was calculated by dividing the determined levels by the initial number of ref mRNA transcripts added to the samples.
+ Open protocol
+ Expand
6

Gradient Fractionation and mRNA Recovery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gradient fractions were thawed on ice, and supplemented with 200 ng of luciferase mRNA (Promega) to control for the efficiency of RNA recovery. Each fraction was extracted with 200 µl of 1-bromo-3-chloropropane. One millilitre of the aqueous phase was transferred to a tube containing 25 µg of glycogen (Ambion), and precipitated using 1 ml of isopropanol. After collecting the precipitate by centrifugation, the pellet was washed in 75% ethanol. The pellets were suspended in 200 µl of water, purified using RNEasy MinElute columns (Qiagen), and suspended in 50–100 µl of RNAse-free water. qPCR reactions were performed using the Roche Universal Probe Library as described above. To control for RNA recovery, Ct values were corrected against the Ct value for luciferase mRNA. For each gene, the transcript levels present in each fraction were further normalized against the total signal from all fractions from the same gradient, and expressed as percentage of total signal. On the basis of the positions of the peaks on the OD (254 nm) traces, fractions 1–12 were designated non-translated and fractions 13–20 were designated translated.
+ Open protocol
+ Expand
7

Quantifying RNA Isolation and Reverse Transcription

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from the groups of oocytes with the RNeasy Micro Kit (Qiagen, Hilden, Germany) following manufacturer’s instructions. Five picograms of luciferase mRNA (Promega, The Netherlands) were added to each group prior to RNA isolation to account for RNA loss during the isolation process. During the procedure, RNA was treated with DNase I to exclude any potential genomic DNA contamination. Isolated RNA was eluted in 12 μL RNase-free water and immediately used for reverse transcription polymerase chain reaction (RT-PCR). Reverse transcription was performed in a final volume of 20 μL, consisting of 75 mM KCl, 50 mM Tris- HCl (pH 8.3), 5 mM DTT, 3 mM MgCl2, 1 mM dNTPs, 2.5 μM random hexamer primers, 20 U RNase OUT and 100 U SuperScript III RT (all purchased at Invitrogen Corporation, Carlsbad, CA, USA). The reaction tubes were incubated at 25 °C for 10 min, at 42 °C for 1 h and at 70 °C for 15 min to inactivate the reaction. One tube without RNA and one with RNA, but without reverse transcriptase, were analyzed as negative controls. To quantify the mRNA recovery rate, 5 pg of luciferase mRNA (not subjected to RNA isolation) were subjected to cDNA synthesis as well.
+ Open protocol
+ Expand
8

Synthesis and Purification of RNA/DNA Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten- or 20-bp synthetic dsRNAs were ordered in dialyzed lyophilized powder from Bioneer (Korea) and resuspended in a suitable amount of TDW at pH 7 and stored at −20°C. The 100-bp poly AU RNA was purchased from Santa Cruz Biotechnology (USA) and handled in the same way. For long ssRNA, luciferase mRNA (Promega, USA) was used and dissolved in a suitable amount of TDW. For long dsRNA, pcDNA3 EGFP plasmid was used as a template to synthesize sense and antisense RNA using MEGAscript T7 transcription kit (Thermo Fisher Scientific, USA). For the dsDNA sample, EGFP PCR product, used as a template for dsRNA, was utilized, and pri-miRNA hairpin RNAs were synthesized from cDNA library using MEGAscript T7 transcription kit following the previous publication.29 (link) Briefly, cDNA library was amplified using forward (5′-TAATACGACTCACTATAGGGCCTATTCAGTTACAGCG-3′) and reverse (5′-GTTGCTAGCTTCAGTACG-3′) primers. The PCR product was used as a template for in vitro transcription. Transcribed RNA was column purified using the MEGAclear Transcription Clean-Up kit (Thermo Fisher Scientific, USA).
+ Open protocol
+ Expand
9

Testis RNA Extraction and Real-Time PCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Testis RNA was extracted using Trizol (Life Technologies, Paisley, UK) and levels of specific mRNA species were measured by real-time PCR. Total RNA was reverse transcribed using random hexamers and Moloney murine leukaemia virus reverse transcriptase (Superscript III, Fisher Scientific UK Ltd., Loughborough, UK) as described previously [25 (link)]. To normalise the data, external standard (luciferase mRNA: Promega UK, Southampton, UK) was added to each testis at the start of the RNA extraction [26 (link)]. For real-time PCR the SYBR green method was used with SYBR mastermix (Agilent Technologies, Wokingham, UK) [27 (link)]. All primers were designed by Primer Express 2.0 (Applied Biosystems, Warrington, UK) or Primer-BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi) using parameters previously described [28 (link)] and the primers used are described in Additional file 2. Transcript levels were normalised to the luciferase external standard, which generates a relative value of transcript expression per testis [29 (link)].
+ Open protocol
+ Expand
10

In Vitro Translation Rate Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro translation rates represent the increase in luminescence as a function of time using a standard rabbit reticulocyte lysate system (Promega) with luciferase mRNA (Promega). Manufacturer’s instructions were followed with a few modifications. Briefly, each reaction (30 μl) contains 12.6 μl of rabbit reticulocyte lysate, 0.5 μl of luciferase mRNA (1 mg/ml), 0.3 μl of amino acid mixture minus leucine (1 mM), 0.3 μl of amino acid mixture minus methionine (1 mM), 2 μl of TEV protease (15 μM), and 14.3 μl of 5 μM protein (MBP-FUS/FMRP) or buffer [25 mM sodium phosphate (pH 7.4), 50 mM KCl, and 2 mM DTT). First, the reaction was incubated for 10 min, and then, end-point luminescence measurements were carried out in intervals of 10 min up to 50 min. Each end-point luminescence measurement contained 75 μl of luciferase substrate mixed with 2.5 μl of unpurified translation mixture measured in a white opaque 96-well plate (Corning 3990). A SpectraMax i3× multimode plate reader (Molecular Devices) at 25°C was used to detect the luminescence. The translation rates represent the line of best fit from the end-point luminescence readings as a function of time.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!